معرفی
Dr. Christine Dufès is a Reader (Associate Professor) in Nanomedicine and Director of the Postgraduate School at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) at the University of Strathclyde. She teaches on the Master of Pharmacy program and various MSc postgraduate degrees, and is actively accepting PhD students for research projects in tumour-targeted nanomedicine development.
Christine holds a Doctorate in Pharmacy and a PhD with a European Label, both earned with Distinction from the University of Poitiers, France. After four years as a post-doctoral researcher at Cancer Research UK Beatson Laboratories in Glasgow, she joined SIPBS as a Lecturer. Her academic journey has led to significant contributions in nanomedicine research and teaching excellence.
Dr. Dufès' research laboratory pioneers two key areas: tumour-targeted therapeutics for cancer therapy and brain-targeted nanomedicines. Her work develops innovative drug- and gene-based nanomedicines capable of reaching specific targets after intravenous administration. This research has produced breakthroughs in prostate cancer treatment, melanoma therapy, and brain delivery systems for neurodegenerative disorders, with multiple approaches demonstrating complete tumour disappearance in preclinical models.
Her publication record includes 56 publications, 4 book chapters, and has attracted over 4600 citations (h-index: 36). Recent work focuses on redox-sensitive dendrimersomes, gold nanocages, and natural compound delivery systems, with increasing emphasis on brain-targeted therapies and combination treatments showing synergistic effects.
Dr. Dufès has received numerous prestigious awards:
- Bourse d'Excellence Lavoisier (2002)
- UK & Ireland Controlled Release Society Award (2003)
- Biochemical Journal Young Investigator Award (2009)
- Tom Gibson Memorial Award (2012)
- Scientist Medal of the International Association of Advanced Materials (2021)
- Outstanding Woman Researcher in Nanomedicine award (2021)
- "Best Overall" Strathclyde Teaching Excellence Award (2013)
- Multiple shortlistings for "Best in Faculty of Science" (2015, 2018, 2022)
All 12 of her PhD students have successfully completed their theses within timeframe and established careers in academia or industry. She has secured significant research funding including a Worldwide Cancer Research grant for prostate cancer nanomedicine development (2016-2019) and participation in the BBSRC-funded NMR-BASE project (2023-2024). Her academic service includes being a Fellow of the Royal Society of Biology, Trustee of the British Society of Nanomedicine, and editorial board member for six journals including Journal of Liposome Research and Biomaterials Science.
She leads the Dufes Lab (http://www.dufeslab.com/), which continues to advance nanomedicine research with a focus on translating laboratory discoveries into potential clinical applications for cancer and neurological disorders.
